Medical Health Cluster

Vacunas

SARS-CoV-2 Stays in GI Tract Long After It Clears the Lungs

New data present further evidence that SARS-CoV-2 infection can settle in the gastrointestinal (GI) tract and that it can persist long after the infection has cleared the lungs. Infection of the GI tract may figure prominently in long COVID, the study authors suggest. Led by Aravind Natarajan, PhD, with the […]

Read More

Covid’s toll in the U.S. reaches a once unfathomable number: 1 million deaths 

The U.S. on Wednesday surpassed 1 million Covid-19 deaths, according to data compiled by NBC News — a once unthinkable scale of loss even for the country with the world’s highest recorded toll from the virus. The number — equivalent to the population of San Jose, California, the 10th largest city in […]

Read More

CDC Predicts a Rise in COVID Hospitalizations and Deaths in Coming Weeks

Coronavirus-related hospital admissions and deaths in the U.S. are projected to increase over the next four weeks, according to a national forecast used by the CDC. The national model also predicts that about 5,000 deaths will occur over the next two weeks, with Ohio, New Jersey, and New York projected to see the largest […]

Read More

Long COVID ‘Brain Fog’ Shares Features With ‘Chemo Brain’

The “brain fog” reported by some people after COVID-19 shows striking similarities to the condition known as “chemo brain” – the mental cloudiness some people experience during and after cancer treatment, according to new research. People who had COVID-19 “frequently experience lingering neurological symptoms, including impairment in attention, concentration, speed […]

Read More

WHO: 14.9 Million Died Because of COVID in 2020–2021

The World Health has issued new estimates on the deadliness of the COVID pandemic, saying 14.9 million people died “directly or indirectly” because of coronavirus between January 2020 and December 2021. In a news release, WHO said its analysis included indirect COVID deaths, defined as occurring when people could not obtain […]

Read More

The Importance of Toxin Testing in C difficile Infection: Understanding the Results

Clostridioides difficile infection (CDI) is often confirmed through toxin testing, yet toxin tests alone may not be sufficient for diagnosing and guiding treatment decisions for patients with CDI. Dr David Lyerly “The presence of a toxigenic strain does not always equal disease,” said David Lyerly, PhD, during a session on C difficile toxin […]

Read More

EU: 2 de cada 3 niños menores de 4 años han tenido COVID debido a ómicron, señala estudio

Según un análisis en la población de Estados Unidos, el 68 por ciento de los niños de entre uno y cuatro años del país se han contagiado de COVID-19. Esto se debería, de acuerdo con un estudio, al incremento de casos por la variante ómicron y su capacidad de transmisión. La […]

Read More

Latest COVID Subvariants Create New Waves, Evade Immunity

As COVID-19 cases and hospitalizations begin to increase again in the U.S., public health officials are monitoring several new Omicron subvariants that are contributing to the case numbers. In some parts of the U.S., a spinoff of the BA.2 subvariant called BA.2.12.1 is the main culprit. In other countries, Omicron […]

Read More

Infección por ómicron a 20 días de haber padecido delta: el periodo más corto conocido de reinfección por SARS-CoV-2

Durante el European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) de 2022, en Lisboa, Portugal, un grupo de investigadores españoles presentó el interesante caso de una mujer de 31 años que fue positiva a ómicron a solo 20 días de ser positiva a delta. Este tiempo de diferencia entre infecciones es el más corto […]

Read More

New Data Confirm Risk of Guillain-Barre With J&J COVID Shot

New surveillance data from the Vaccine Safety Datalink confirm a small but statistically significant increased risk for Guillain-Barré syndrome (GBS) in the 3 weeks after receipt of the Janssen/Johnson & Johnson COVID-19 vaccine. The Janssen vaccine (Ad26.COV2.S) is a replication-incompetent adenoviral vector vaccine. The data show no increased risk of […]

Read More